diabetes

Lilly’s diabetes med Trulicity shrugs off Novo Nordisk challenge
Pharmaforum
Fri, 01/31/20 - 11:03 am
Eli Lilly
Trulicity
diabetes
FDA Approves Eli Lilly's and Boehringer Ingelheim Pharmaceuticals' Triple-Combination Diabetes Drug Trijardy XR
Motley Fool
Tue, 01/28/20 - 12:04 pm
FDA
Eli Lilly
Boehringer Ingelheim
Trijardy XR
Jardiance
Tradjenta
metformin
diabetes
Eli Lilly Donates Insulin KwikPens to Support Free Clinics in the U.S.
BioSpace
Tue, 01/28/20 - 11:53 am
Eli Lilly
insulin
diabetes
KwikPens
philanthropy
It’s the insulin, stupid: How drug pricing’s simplest case study became a top issue for 2020 Democrats
Stat
Tue, 01/28/20 - 11:01 am
drug pricing
diabetes
insulin
2020 Presidential election
Abbott’s Diabetes Device Dominates As CEO White Hands Over Reigns
Forbes
Wed, 01/22/20 - 11:04 am
Abbott Labs
Miles White
Pharma CEOs
devices
FreeStyle Libre
diabetes
JPM: Biotech, VC execs on where the industry should look beyond cancer
Fierce Biotech
Fri, 01/17/20 - 12:34 pm
oncology
cancer
Alzheimer's disease
diabetes
venture capital
JPMHC 2020
Novo Nordisk's blockbuster Ozempic wins FDA label boost with CV indication
Endpoints
Fri, 01/17/20 - 11:15 am
Novo Nordisk
Ozempic
diabetes
cardiovascular events
FDA
Tandem Diabetes Launches a New Version of Its Insulin Pump
Motley Fool
Wed, 01/15/20 - 11:25 pm
Tandem Diabetes
diabetes
insulin pumps
devices
Eli Lilly Releasing Cheaper Insulin Generic to Compete With Lispro Products
Motley Fool
Tue, 01/14/20 - 10:07 pm
Eli Lilly
generics
insulin
diabetes
Lispro
Abbott Kicks in for Bigfoot's $45M Financing
Medical Devices and Diagnostics Industry
Tue, 01/14/20 - 10:12 am
Bigfoot Biomedical Abbott Labs
devices
diabetes
FDA OKs Novo's Fiasp for diabetic children
Seeking Alpha
Mon, 01/6/20 - 10:36 am
insulin
FDA
Novo Nordisk
Fiasp
pediatrics
diabetes
type 1 diabetes
Novo Nordisk Launches $99 Insulin Program
BioSpace
Thu, 01/2/20 - 11:41 pm
Novo Nordisk
diabetes
insulin
drug pricing
High Cost of Insulin Remains a Concern as Lawmakers Head into 2020 Election
BioSpace
Thu, 01/2/20 - 10:58 am
diabetes
insulin
drug pricing
2020 Presidential election
After 'nonsense' retort, Lilly CEO urges patients to seek its help affording insulin
Fierce Pharma
Thu, 12/19/19 - 11:09 pm
Eli Lilly
David Ricks
Pharma CEOs
insulin
patients
diabetes
FDA takes another step to encourage copycat insulin products
Pharmaforum
Wed, 12/18/19 - 10:37 am
FDA
diabetes
insulin
biosimilars
Are Changes in Store for Verily’s Diabetes Joint Venture?
Medical Devices and Diagnostics Industry
Tue, 12/17/19 - 10:36 am
Verily
Sanofi
diabetes
Onduo
digital health
Lilly doubles down on Dexcom tech for connected insulin devices
Pharmaforum
Tue, 12/17/19 - 10:24 am
Eli Lilly
DexCom
continuous glucose monitoring
devices
diabetes
Sanofi Says Its $2.5 Billion Biotech Takeover Is Just the Beginning
Motley Fool
Sun, 12/15/19 - 12:15 am
Sanofi
M&A
immuno-oncology
Lantus
diabetes
Eli Lilly, Boehringer's Jardiance flops heart failure trial, falling behind AZ's Farxiga
Fierce Pharma
Fri, 12/13/19 - 09:05 pm
Eli Lilly
Boehringer Ingelheim
Jardiance
Farxiga
diabetes
AstraZeneca
heart failure
Sanofi CEO Hudson backs away from struggling diabetes, cardiovascular areas in strategy unveiling
Fierce Pharma
Tue, 12/10/19 - 10:56 am
Sanofi
Paul Hudson
Pharma CEOs
diabetes
cardiovascular death

Pages